Effect of the serotonin4 receptor agonist cisapride on plasma aldosterone levels in cirrhotic patients with secondary hyperaldosteronism

European Journal of Clinical Pharmacology

Volumn 53, Issue 6, 1998, Pages 479-480

  Lefebvre, H ^a   Heron, F ^a   Contesse, V ^a   Delarue, C ^a   Vaudry, H ^a   Kuhn, J M ^a  

^a Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

Author keywords

5 HT4 receptor; Adrenal gland; Aldosterone; Cirrhosis; Cisapride; Secondary hyperaldosteronis

Indexed keywords

CISAPRIDE; ALDOSTERONE; PIPERIDINE DERIVATIVE; SEROTONIN AGONIST;

ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; DRUG CONTRAINDICATION; DRUG EFFECT; HORMONAL REGULATION; HUMAN; HYPERALDOSTERONISM; LETTER; LIVER CIRRHOSIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; BLOOD; CLINICAL TRIAL; FEMALE; MALE;

ALDOSTERONE; CISAPRIDE; FEMALE; HUMANS; HYPERALDOSTERONISM; LIVER CIRRHOSIS; MALE; PIPERIDINES; SEROTONIN AGONISTS;

EID: 0031596528     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050410     Document Type: Letter

References (4)